Now Recruiting

A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101).

Now Recruiting

A Study of SNDX-5613 in Combination With Chemotherapy in Participants With Leukemia (AUGMENT-102).